Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1996-01-30
1998-06-09
Feisee, Lila
Drug, bio-affecting and body treating compositions
Lymphokine
4241981, 424 852, 424 855, 4241581, 514 12, 530350, 530351, 530381, A61K 4505, A61K 3819, A61K 3806, C07K 100
Patent
active
057629218
ABSTRACT:
The invention concerns a method for inducing a selective collapse of the vasculature of a solid tumor by administering to a patient a therapeutically effective dose of a combination of a compound preventing the formation of a functional thrombin-thrombomodulin complex and a cytokine selected from the group of TNF-.beta. (LT), TNF-.alpha., IL-1, and IFN-.gamma.. The invention further concerns the composition used in this method.
REFERENCES:
patent: 4506009 (1985-03-01), Lenhoff et al.
patent: 5147638 (1992-09-01), Esmon et al.
patent: 5196404 (1993-03-01), Maraganore et al.
Bode and Stubbs, "Spatial Structure of Thrombin as a Guide to Its Multiple Sites of Interaction," Seminars in Thromb. and Hemostasis 19(4): 321-333 (1993).
Burrows and Thorpe, "Eradication of Large solid tumors in mice with an Immunotoxin Directed Against Tumor Vasculature," Proc. Natl. Acad. Sci. USA 90: 8996-9000 (1993).
Constantini and Zacharski, "Fibrin and Cancer," Thromb. Haemost. 69, 406-414 (1993).
de Fouw, N.J. et al., "The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells," Thromb. Haemost. 57(2), 176-182 (1987).
de Fouw, N.J. et al., Fibrinogen, Thrombosis, Coagulation and Fibrinolysis., CY Liu and S. Chien, Eds. 235-243 (1990).
Esmon, C.T., "Protein S and Protein C, Biochemistry, Physiology, and Clinical Manifestation of Deficiencies," Trends in Cardiovasc. Med. 2, 214-219 (1992).
Esmon, N., "Thrombomodulin," Prog. Hemost. Thr. 9: 29-55 (1988).
Esmon, C., "The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation," J. Biol. Chem. 264, 4743-4746 (1989).
Glassman et al., "Thrombosis and Coagulation Abnormalities Associated with Cancer," Ann. Clin. Lab. Sci. 24, 1-5 (1994).
Ikeda and Stenflo, "A Radioimmunoassay for Protein C," Thrombosis Res. 39: 297-306 (1985).
Lehr, H. et al., Am. J. Pathol. 143: 1055-1062 (1993).
Leunig, M. et al., Cancer Res. 52: 6553-6560 (1992).
Miyamoto, S. et al., "Characterization of Heat-Treated Preparation of Human Protein C/Activated Protein C," Thromb. Haemost. 62: 920 (1989).
Nishioka, J. et al., "Estimation of the Possible Recongnition Sites for Thrombomdulin, Procoagulant, and Anti-coagulant Proteins around the Active Center of .alpha.-Thrombin," J. Biochem. 114: 148-155 (1993).
Nydahl, S. et al., "Thrombin Inactivation and the Effects of Antithrombin and Heparin in a Recirculating Langendorff Preparation,"Thrombosis Res. 65, 365-376 (1992).
Nydahl, S. et al., "Effect of Heparin on Thrombin Inhibition in the Microcirculation," Thromb. Haemost. 69, 41-44 (1993).
Palladino, M. et al., "Characterization of the Antitumor Activities of Human Tumor Necrosis Factor-.alpha. and the Comparison with other Cytokines: Induction of Tumor-Specific Immunity," J. Immunol. 138: 4023-4032 (1987).
Sakata, Y. et al., "Activated Protein C Stimulates the Fibrinolytic Activity of Cultured Endothelial Cells and Decreases Antiactivator Activity," Proc. Natl. Acad. Sci. USA 82, 1121-1125 (1985).
Sakata, Y. et al., "Mechanism of Protein C-Dependent Clot Lysis: Role of Plasminogen Activator Inhibitor," Blood 68, 1218-1223 (1986).
Scates, "Diagnosis and Treatment of Cancer-Related Thrombosis," Sem. Thromb. Hemost. 18, 373-379 (1992).
Suzuki, K. et al., "Localization of Thrombomodulin-binding Site within Human Thrombin," J. Biol. Chem. 265 (22): 13263-13267 (1990).
Tanaka, S. et al., "Anti-Protein C Monoclonal Antibody Induces Thrombus In Mouse," Thromb. Haemost. 62: 377 (1989).
Taylor et al., "Protein C Prevents the Coagulopathic and Lethal Effects of Escherichia Coli Infusion in the Baboon," J. Clin. Invest. 79, 918-925 (1987).
Walker, F.J. and Fay, P.J., "Regulation of Blood Coagulation by the Protein C System," FASEB J. 6, 2561-2567 (1992).
Zacharski, "Basis for Selection of Anticoagulant Drugs for Therapeutic Trials in Human Malignancy," Haemostasis 16, 300-320 (1986).
Zacharski et al., "The Coagulation Biology of Cancer, " Fibrinolysis 6, 39-42 (1992).
Esmon, C.T., "The regulation of natural anticoagulant pathway" Science 235:1348-1352 (1987).
Jackman et al., "Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor" Proc. Natl. Acad. Sci. USA 83:8834-8838 (1986).
Jackman et al., "Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control" Proc. Natl. Acad. Sci. USA 84:6425-6429 (1987).
Kurosawa et al., "A 10-KDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site" Journal of Biological Chemistry 263:5993-5996 (1988).
Suzuki et al., "Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation" EMBO Journal 6:1891-1897 (1987).
Wen et al., "Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene" Biochemistry 26:4350-4357 (1987).
Zacharski, "Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy" Haemostasis 16:300-320 (1986).
Zacharski et al., "The coagulation biology of cancer" Fibrinolysis 6:39-42 (1992).
Zushi et al., "The last three consective epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity" Journal of Biological Chemistry 264:10351-10353 (1989).
Bansal Geetha P.
Dreger Ginger R.
Feisee Lila
Genentech Inc.
LandOfFree
Composition and methods for the treatment of tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and methods for the treatment of tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and methods for the treatment of tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2195821